SCHEMBL753458

SCHEMBL753458

c1ccc(-p2c3cc4c5sc6ccccc6c5p(-c5ccccc5)c4cc3c3sc4ccccc4c32)cc1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GPR3 P46089 1/20 0.39
▸ MAPT P10636 4/20 0.39
▸ RAB9A P51151 3/20 0.39
▸ MEN1 O00255 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ ALDH1A1 P00352 5/20 0.36
▸ L3MBTL1 Q9Y468 3/20 0.36
▸ TNKS O95271 2/20 0.36
▸ TNKS2 Q9H2K2 2/20 0.36
▸ HCRTR1 O43613 1/20 0.36
▸ LMNA P02545 1/20 0.36
▸ POLB P06746 1/20 0.36
▸ ATM Q13315 1/20 0.35
▸ KDM4E B2RXH2 1/20 0.35
▸ HPGD P15428 1/20 0.33
▸ SMN1; SMN2 Q16637 1/20 0.33
▸ ALOX5 P09917 1/20 0.33
▸ LIMK1 P53667 1/20 0.33
▸ CDK5 Q00535 1/20 0.33
▸ CDK5R1 Q15078 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL753643 0.89 MAPT (0.39) GPR3MAPTRAB9AMEN1KMT2A
SCHEMBL17951774 0.88 GPR3 (0.40) GPR3MAPTRAB9AMEN1KMT2A
SCHEMBL755314 0.77 GPR3 (0.40) GPR3MAPTRAB9AMEN1KMT2A
SCHEMBL752678 0.75 LIMK1 (0.40) RAB9AMEN1KMT2ATNKSTNKS2
SCHEMBL753503 0.67 KDM4E (0.30) MEN1KMT2AALDH1A1KDM4EHPGD
SCHEMBL10053709 0.67 GPR3 (0.44) GPR3MAPTRAB9AMEN1KMT2A
SCHEMBL29700327 0.65 GPR3 (0.67) GPR3MAPTRAB9AMEN1KMT2A
SCHEMBL430470 0.65 GPR3 (0.67) GPR3MAPTRAB9AMEN1KMT2A
Dibenzothiophene SCHEMBL21121001 0.62 GPR3 (0.93) GPR3MAPTRAB9AMEN1KMT2A
Dibenzothiophene SCHEMBL28316922 0.62 GPR3 (0.93) GPR3MAPTRAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138355-B2 Heteroacene derivative, tetrahaloterphenyl derivative, and processes for producing the same TOSOH CORPORATION (JP) 2012-03-20 — — US disclosed
US-8138355-B2 Heteroacene derivative, tetrahaloterphenyl derivative, and processes for producing the same TOSOH CORPORATION (JP) 2012-03-20 — — US disclosed
US-20090261300-A1 HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME TOSOH CORPORATION (JP) 2009-10-22 — — US disclosed
US-20090261300-A1 HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME TOSOH CORPORATION (JP) 2009-10-22 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090261300-A1 HETEROACENE DERIVATIVE, TETRAHALOTERPHENYL DERIVATIVE, AND PROCESSES FOR PRODUCING THE SAME AS3MT, TERT, TEAD1 GPR3 3625/4885MAPT 1194/4885RAB9A 2564/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback